Global 3D Cell Culture Market by Product, Application, End-user and Geography - Forecast to 2026 -

DUBLIN--()--The "3D Cell Culture Market by Product, by Application, by End-User, by Geography - Global Opportunity Analysis and Industry Forecast up to 2026" report has been added to's offering.

The early-stage drug discovery and other related research have earned 3D cell structure increasing popularity which can be seen in its growing application.

3D cell culture is growing at a fast pace in the healthcare environment because of the significant scale of implementations in various areas like cancer research, vitro environment, and regenerative medicine. It has the potential to understand tissue maturation and formation, organogenesis, and cell differentiation has increased its utility. Now animal prototypes in clinical testing and experiments are replaced because of its similarity with cells in vivo.

The 3D cell culture market is majorly driven through the increasing usage of 3D cell culture in diagnostic centers, hospitals, pharmaceutical, and biotech companies. Which directly increases the demand for organ transplantation, tissue regeneration, and regenerative medicine.

The report also contains insight regarding technological innovations and advanced solutions for the 3D Cell Culture. The study also gives an in-depth idea about the major competitors in the market, their journey and the competitive edge via systematic analytical tools including SWOT analysis.

The estimated market value of 3D Cell Culture in 2020 is US$ 2,717.6 million and it is predicted that it will grow at a CAGR of 29.1%.

There are three important factors which are the driving forces behind the growth of 3D Cell Culture market, the key features which have fueled its increased its growth are:

  • The Rise in the Prevalence Rate of Cancer
  • Growing Focus on Personalized Medicine
  • High Degree of Corporate Inclusion for Research

The physiologic, histologic, and functional properties of the respective tissues have given the homotypic and heterotypic 3D tissue culture models. These properties enhance the different cellular functions such as adhesion, migration, gene expression, and proliferation.

The creation of duct-like structures in vitro environments can be formed by two important factors such as normal polarization and differentiation of epithelial cells as well as with the usage of 3D cultures. Moreover, the synergistic effect required for the interactions of cell-cell and cell-extracellular matrix (ECM), which can control the expression of molecules involved in cell differentiation, is also achieved in 3D cell cultures.

The potential that 3D models have so that it can minimize the accompanying flaws with 2D monolayer cultures is predetermined to fuel the demand for these techniques in the near future. The rising demand from the shift of 2D to 3D technology is pushing the growth of this market. In addition, opportunistic marketing competitors are entering this segment due to its high market potential. Subsequently, this will further propel the market.

These technologies provide advanced tools that can help to explore key aspects of disease and enable demonstration of micro-environmental factors that support in-vivo tumor growth. 3D concept of artificial cell cultivation provides vast benefits in the analysis of phenotypic heterogeneity of cancers and heterotypic intercellular crosstalk for 3D Cell Culture vendors to fulfill both the residential as well as commercial sectors.

Key Topics Covered

1. Industry Outlook

  • Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
  • DRO - Impact Analysis

2. End-user: Market Size & Analysis

  • Overview
  • Pharmaceutical & Biotechnology Companies
  • Research Institutes
  • Cosmetics Industry
  • Other End-users

3. Application: Market Size & Analysis

  • Overview
  • Cancer & Stem Cell Research
  • Drug Discovery & Toxicology Testing
  • Tissue Engineering & Regenerative Medicine

4. Technology: Market Size & Analysis

  • Overview
  • Scaffold-based 3D Cell Cultures
  • Hydrogels/ECM Analogs
  • Solid Scaffolds
  • Micropatterned Surfaces
  • Scaffold-free 3D Cell Cultures
  • Low Attachment Plates
  • Hanging Drop Plates
  • 3D Bioreactors
  • 3D Petri Dishes
  • Microfluidics-based 3D Cell Cultures
  • Magnetic & Bioprinted 3D Cell Cultures

5. Geography: Market Size & Analysis

  • Overview
  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

6. Competitive Landscape

  • Competitor Comparison Analysis
  • Market Developments
  • Mergers and Acquisitions, Legal, Awards, Partnerships
  • Product Launches and execution

Companies Mentioned

  • 3D Biotek, LLC
  • Advanced Biomatrix, Inc.
  • Becton, Dickinson and Company
  • Corning Incorporated
  • Kuraray Co. Ltd.
  • Lonza Group Ltd.
  • Merck & Co. Inc.
  • Synthecon Incorporated
  • Thermo Fisher Scientific Inc.
  • VWR Corporation

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900